(Q36982694)

17 August 2017

1 reference

title

Antidepressant agents for the treatment of chronic pain and depression (English)

1 reference

17 August 2017

0 references

Michael W Jann

1

1 reference

17 August 2017

Julian H Slade

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

27

1 reference

17 August 2017

issue

11

1 reference

17 August 2017

page(s)

1571-1587

1 reference

The epidemiology of pain in depression

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Molecular mechanisms of nociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Neuronal plasticity: increasing the gain in pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Pain: Molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Automatic and strategic processing of threat cues in patients with chronic pain: a modified stroop evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

The clinical picture of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Understanding pain in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

The origin of brainstem noradrenergic and serotonergic projections to the spinal cord dorsal horn in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

The projection of noradrenergic neurons in the A7 catecholamine cell group to the spinal cord in the rat demonstrated by anterograde tracing combined with immunocytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Pain genes?: natural variation and transgenic mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

The use of antidepressants in the treatment of chronic pain. A review of the current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Serotonin and noradrenaline reuptake inhibitors in animal models of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

21 January 2018

Antidepressants and pain

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Treatment of pain syndromes with venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Efficacy of venlafaxine for the long term treatment of chronic pain with associated major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

The outcome of physical symptoms with treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Duloxetine vs. placebo in patients with painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1571

21 January 2018

Identifiers

DOI

10.1592/PHCO.27.11.1571

1 reference

17 August 2017

1 reference